Relaxo Footwears Limited Stocks

305.08Last Updated 15.04.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

₹ 786.14M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
305.08
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Relaxo Footwears Limited manufactures and sells footwear for men, women, and kids in India and internationally. It offers casual, running, athleisure, walking, formal, sports, school, and training and gym shoes. The company also provides slippers, sandals, flip flops, slides, chappals, casuals, belles, and clogs. In addition, it offers footwear accessories. The company provides its products under the Relaxo, Bahamas, Flite, Sparx, BOSTON, and Mary Jane brands. It sells its products through 394 exclusive brand outlets; and e-commerce portals. Relaxo Footwears Limited was founded in 1976 and is based in New Delhi, India.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of RELAXO.NS is 513 and suggests 74% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks